Nebulizers are useful in medication delivery for patients with certain respiratory conditions and disease severity. However, the size, power supply constraints, and inefficiency of traditional pneumatic or T-piece nebulizers can often deter clinicians from recommending them. Additionally, some patients who are prescribed nebulizers may not use them if they view the devices as burdensome – either due to lengthy treatment time, cleaning and maintenance requirements, the number of parts that need to be assembled, or a combination of the three.
“For patients who are home-bound or relatively immobile and require higher-volume treatments over longer periods of time, traditional nebulizers are a great aerosol delivery solution. They provide the power patients require in the comfort of their care setting,” said James Fink, PhD, RRT, FAARC, FCCP (Chief Science Officer at Aerogen Pharma Corporation). “However, active patients with conditions such as COPD and asthma can find nebulizer use limiting and time-consuming, which can impact therapy success.”